MURA
Income statement / Annual
Last year (2023), Mural Oncology plc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Mural Oncology plc's net income was -$207.45 M.
See Mural Oncology plc,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$2.57 M
|
$1.54 M
|
$1.47 M
|
Gross Profit |
-$2.57 M
|
-$1.54 M
|
-$1.47 M
|
Gross Profit Ratio |
0
|
0
|
0
|
Research and Development Expenses |
$162.03 M
|
$170.07 M
|
$159.82 M
|
General & Administrative Expenses |
$30.71 M
|
$25.08 M
|
$15.55 M
|
Selling & Marketing Expenses |
-$667,000.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$30.04 M
|
$25.08 M
|
$15.55 M
|
Other Expenses |
$0.00
|
$0.00
|
$0.00
|
Operating Expenses |
$192.07 M
|
$195.15 M
|
$175.37 M
|
Cost And Expenses |
$194.64 M
|
$195.15 M
|
$175.37 M
|
Interest Income |
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$2.57 M
|
$1.54 M
|
$1.47 M
|
EBITDA |
-$192.72 M |
-$183.38 M |
-$173.89 M |
EBITDA Ratio |
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
Total Other Income/Expenses Net |
-$649,000.00
|
$10.22 M
|
$0.00
|
Income Before Tax |
-$195.29 M
|
-$195.15 M
|
-$175.37 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
Income Tax Expense |
$12.16 M
|
$4.88 M
|
$68,000.00
|
Net Income |
-$207.45 M
|
-$200.03 M
|
-$175.43 M
|
Net Income Ratio |
0
|
0
|
0
|
EPS |
-12.43 |
-11.99 |
-10.51 |
EPS Diluted |
-12.43 |
-11.99 |
-10.51 |
Weighted Average Shares Out |
$16.69 M
|
$16.69 M
|
$16.69 M
|
Weighted Average Shares Out Diluted |
$16.69 M
|
$16.69 M
|
$16.69 M
|
Link |
|
|
|